Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Business Officer
-
Stock Symbol
-
CCCC on Nasdaq
Scott N. Boyle - trading volume in the past year for C4 Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
108K |
$340K |
$3.15 |
Feb 18, 2025 |
Direct |
|
|
| Performance Restricted Stock Units |
10.5K |
$63.4K |
$6.04 |
Nov 7, 2024 |
Direct |
Common Stock |
|
| Stock Option (Right to Buy) |
84.7K |
|
|
Feb 14, 2025 |
Direct |
Common Stock |
|
Transactions reported by Scott N. Boyle for C4 Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.